The level of lung cancer glucose metabolism is correlated with a variety of factors, such as glycolysis-related gene expression, tumor immune microenvironment, Ki-67 expression, epidermal growth factor receptor, and tumor protein 53 mutation, among others [20–22]. This evidence concerns the gene TP53 and lung cancer.